Cell & Gene CMO Sourcing Center

Cell & Gene Sourcing Center

The number of clinical trials in cell and gene therapy has exploded – estimates are of over 1,000 clinical trials ongoing globally.

Many of these new therapeutic approaches require the production of viral vectors. Viral vector manufacturing today is cumbersome, and the yields are poor. If you are a startup biotech in need of viral vectors today, getting into capacity could be an issue. Complicating matters, cell and gene therapies require a certain proximity to patient and process/treatment centers, which will keep most U.S.-based drug and therapy developers looking for domestic (and regional) partners.

How can we help?

Looking for help with your Cell & Gene project? If you're searching for information or a supplier, let Life Science Connect lend you a hand.

Submit A Question

Cell & Gene CMOs

Cell & Gene Manufacturing CMO - AGC Biologics
AGC Biologics

AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) committed to delivering the highest standard of service and collaboration to our clients and partners as we work side-by-side to help bring their products to patients across the globe. We offer world-class development and manufacturing services of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA) viral vectors, and genetically engineered cells.

Cell & Gene CMO - Ajinomoto Bio-Pharma Services
Ajinomoto Bio-Pharma Services

Working with Ajinomoto Bio-Pharma Services, you get a trusted CDMO partner that has the power to make your every challenge our own, sharing your unwavering tenacity and dedication from pre-clinical program to commercial successes. We leverage our broad range of capabilities and services at our sites in Belgium, India, Japan, and the US to support your program goals.


Cell & Gene CMO - Aldevron

For 25 years Aldevron has been a catalyst, advancing therapeutic and vaccine development through expert plasmid DNA, RNA, and protein custom manufacturing, supporting our clients from discovery to commercialization. Our custom CDMO services have given scientists around the world essential components to accelerate their research and make a difference. Whether you're working on a gene therapy, cell therapy, or vaccine development, it starts with a high-quality DNA, RNA, or Protein.

Have questions about selecting the right CMO?

The Life Science Connect team can help. We'll match your needs with the right companies.

Contact us via email for assistance.

Cell & Gene CMO - Andelyn Biosciences
Andelyn Biosciences

Andelyn Biosciences is a pioneering gene therapy organization born out of Nationwide Children's Hospital, where the first FDA-approved systemic gene therapy was discovered.

With more than 15 years of experience in AAV vector manufacturing, Andelyn is a full-spectrum CDMO. We bring scalability, capacity, efficiency and expert resources to manufacturing matrices, all to advance the development of viral vector-based therapeutics.


Cell & Gene CMO - BioCentriq

BioCentriq is a full-service, New Jersey-based CDMO for cell and gene therapy, focusing on all stages of process development and clinical manufacturing. With over 70 scientists, engineers, analysts, and manufacturing specialists, we have the quality systems and infrastructure required to support the release of both autologous and allogeneic drug products. BioCentriq also specializes in viral vector process development and manufacturing with expertise in a variety of cell and vector types.

Cell & Gene CMO - Cardinal Health
Cardinal Health

Cardinal Health Advanced Therapy Solutions offers tailored solutions that simplify and streamline complexities of cell and gene therapies (CGT). From clinical development to commercialization, our experts will partner with you every step of the way to ensure your therapy is in the hands of patients who need it most.


Cell & Gene CMO - Catalent

Catalent is a global leader in providing integrated services, superior drug delivery technologies and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics and consumer health products.


Cell & Gene CMO - Cellistic

Cellistic traces its origin to a single imperative: to pave the way to make cell therapy accessible. Through facilities purpose-built for that mission, we help you accelerate the development and manufacture of your cell therapies in a more reliable, affordable, and faster way, using our exclusive Pulse + Echo Platforms. These platforms ensure the highest quality starting cells are scaled and transformed as quickly as possible.


Cell & Gene CMO - Cencora

Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. We are united in our responsibility to create healthier futures.

Cell & Gene CMO - Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises
Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises

Founded in 2003 as a business unit of New York Blood Center Enterprises, Comprehensive Cell Solutions offers its deep expertise in the development and manufacture of cell and gene therapies, using its GMP and GTP facilities. CCS provides a true vein-to-vein solution, spanning fresh cellular collections and cord blood-derived stem cells as source material, to cell isolation, manipulation and cryopreservation for preclinical to commercial products.

Cell & Gene CMO - ElevateBio

ElevateBio is a technology-driven company built to power the development of transformative cell and gene therapies (CGTs). The company's integrated technologies model offers turnkey scale and biotechnological capabilities to power CGT processes, programs, and companies to their full potential. ElevateBio aims to be the dominant engine inside the world's greatest scientific advancements harnessing human cells and genes to alter disease.


Cell & Gene CMO - FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies

FUJIFILM Diosynth Biotechnologies is a CDMO Partner for Life. We combine technical leadership in cell culture, microbial fermentation and advanced therapies with world class cGMP manufacturing facilities and superior program management to advance tomorrow's medicines.

Cell & Gene CMO - GC Cell
GC Cell

GC Cell stands at the forefront of cell therapy innovation, offering a holistic approach that encompasses everything from research and development to bringing products to market. Our mission is to fast-track the innovation in cell and gene therapies, aiming to enhance the clinical outcomes of each & every patient and shape the future of healthcare.


Cell & Gene CMO - IDT Biologika
IDT Biologika

IDT Biologika is a global CDMO for Innovative Vaccines, Cell & Gene Therapeutics and Aseptic Fill-Finish of other biologics. We offer clients a single source CDMO partner at our sites in Germany and the USA, with seamless end-to-end solutions and the ability to nimbly scale projects from development through to commercialization. This includes Process Development, Drug Substance Manufacturing, Sterile Dosage Fill-Finish, Labelling & Packaging, Quality Control & Analytics.

Cell & Gene CMO - Kymanox Corporationh
Kymanox Corporation

Kymanox is a life science professional services organization that offers engineering, scientific, and compliance support to companies exclusively in the biotechnology, pharmaceutical, medical device, and combination product industries. With its diverse team, Kymanox helps clients navigate commercialization challenges that arise throughout a product's lifecycle – from early development to post-market commercialization – with optimized safety, quality, efficacy, and accessibility.

Cell & Gene CMO - Lonza

Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our unparalleled breadth of offerings enables our customers to commercialize their discoveries and innovations in the healthcare industry.

Cell & Gene CMO - MilliporeSigma

We bring 30+ years of expertise, and a global organization to integrate leading manufacturing technologies with process development, scale-up, safety testing, and the regulatory experience to meet your therapy's needs. We have more experience in this area than almost anyone else in the industry. We were the first gene therapy CDMO to produce commercial product following successful regulatory inspection.


Cell & Gene CMO - Novartis Contract Manufacturing
Novartis Contract Manufacturing

Novartis Contract Manufacturing is a fully integrated CDMO offering end-to-end manufacturing solutions for mammalian, microbial, advanced therapies (pDNA, mRNA, siRNA, autologous cell therapies, viral vectors), oligonucleotides, drug product, device assembly and packaging to meet our clients clinical and commercial supply needs.

Cell & Gene CMO - OBiO Tech
OBiO Tech

OBiO Tech is committed to becoming a leading gene and cell therapy CRO and CDMO to serve our customers worldwide as best as possible. We provide holistic research, development, manufacturing solutions, functional genomics, process and analytical development, IND-enabling CMC, clinical and commercial manufacturing expertise, capabilities, and compliance. Our services with scale include plasmids, mRNA, AAV vector, oncolytic virus, immuno cell therapy, stem cells, and more.


Cell & Gene CMO - Pharmatech Associates - A USP Company
Pharmatech Associates - A USP Company

Pharmatech Associates is a global consultancy for the life science industry and advises U.S. and global drug sponsors and manufacturers to supply quality medicines in all major markets. Pharmatech Associates' domain expertise ranges from small molecule to cell and gene therapy, biologics, and advanced manufacturing technologies. Services to clients include regulatory strategy, compliance, and remediation to address manufacturing quality, CMC, and analytical method qualification.

Cell & Gene CMO - Precision NanoSystems
Precision NanoSystems

Precision NanoSystems is a global leader in technologies, solutions and services for the development of Lipid Nanoparticle delivered genomic medicines, including mRNA vaccines and therapeutics. We support (bio)pharma companies who are ushering in the next wave of genomic medicines in infectious diseases, cancer and rare diseases. We work with the world's leading drug developers to understand disease and help create the therapeutics and vaccines that will define the future of medicine.

Cell & Gene CMO - ReciBioPharm

ReciBioPharm is a contract development and manufacturing organization (CDMO) specifically established to focus on serving companies seeking to develop and commercialise advanced therapy medicinal products (ATMPs). ReciBioPharm's specialised CDMO capabilities include pre-clinical to clinical and commercial development and manufacture for new biological modalities encompassing technologies based on live viruses and viral vectors, live-microbial biopharmaceutical products, nucleic acid-based mRNA and plasmid DNA production.


Cell & Gene CMO - Resilience US, Inc.
Resilience US, Inc.

Resilience is a manufacturing and technology company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption. Founded in 2020, the company is building a sustainable network of high-tech, end-to-end manufacturing solutions with the aim to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale. Resilience seeks to offer regulatory capabilities and flexible and adaptive facilities to serve partners of all sizes.

Cell & Gene CMO - SGS

SGS offers a comprehensive analytical support package to assure the safety, identity, potency, purity and quality of raw materials, drug substances, and drug products to support the manufacture of cell and gene therapy products. With exceptional expertise across our key biopharmaceutical pillars of biosafety, characterization, QC/release and bioanalysis, SGS supports the analytical demands for cell and gene therapy development in compliance with FDA, EMA, ICH, and WHO guidelines.


Cell & Gene CMO - Theragent

Theragent is an advanced therapeutics Contract Development and Manufacturing Organization in Arcadia, CA, focused on accelerating scientifically complex cell- and tissue-based therapies for the treatment of cancer and other diseases with unmet medical needs. Theragent supports projects from very early-stage development through commercial cell therapy manufacturing covering all cell therapy modalities including immunotherapies, stem cells, cell lines, tissue engineering and multicellular products.

Cell & Gene CMO - Vernal Biosciences
Vernal Biosciences

We're Vernal. The industry's only seamless, end-to-end mRNA manufacturing platform that sustainably simplifies, de-risks, and accelerates your path from lead identification through candidate selection, IND and market approval. Our integrated technologies and systems enable the manufacturing of high purity drug substance, drug product, and intermediates using phase-appropriate control strategies.


Cell & Gene CMO - Viralgen

Viralgen is a CDMO that combines decades of technology and drug development experience in multiple platforms to support best-in-class service offerings to the gene therapy market. Through our superior technology platform, we deliver industry-leading titers and cGMP-certified quality for all AAV serotypes to our client partners, optimize the cost-of-goods, and accelerate clinical development and commercialization of life-saving genetic medicines.


Cell & Gene CMO - WuXi Advanced Therapies
WuXi Advanced Therapies

WuXi Advanced Therapies is a Contract Testing, Development and Manufacturing Organization (CTDMO) that offers advanced platforms and end-to-end solutions that enable the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies. Our services and solutions accelerate time to market and support customer programs around the world.